SLC25A44

Across TCGA pan-cancer cohorts, SLC25A44 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated SLC25A44 data layer compared with 20 for mass-spec protein and 2 for mutation status.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where higher SLC25A44 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated SLC25A44 expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.

LSCC and GBM are the cancer types where SLC25A44 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LSCC	DFS	Tertile	All	0.384	0.926	.007	14	view →
GBM	OS	Median	All	0.873	0.661	.043	1	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

SLC25A44–LSCC (DFS)

Open the LSCC breakdown →